🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07122323
Enrolling by invitation Not applicable

Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes Disease

NCT07122323 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Started
2025-07-28
Last updated
2025-08-14

Condition(s) studied

Legg-Calvé-Perthes Disease

Investigational drug(s) / intervention(s)

robotic arm-assisted total hip replacementconventional total hip replacement

robotic arm-assisted total hip replacement: using robotic total hip replacement in patients with Legg-Calvé-Perthes disease

conventional total hip replacement: applying conventional total hip replacement in patients with Legg-Calvé-Perthes disease

Study summary

Flat hip, also called Legg-Calvé-Perthes disease, is clinically characterized by flattened femoral head, shortened femoral neck, and a center of rotation of the femoral head lower than the apex of the greater trochanter. Joint replacement is difficult, with high intraoperative and postoperative complications. Especially, issues such as unequal limb length, postoperative dislocation, postoperative neurological damage, and prosthesis impact have always plagued clinical practice.

The robotic arm-assisted joint replacement technology has been developed and clinically applied for over 10 years, but it was not until the past 3 years that it began to be widely implemented worldwide. Existing research data indicates that robotic arm-assisted joint replacement technology can significantly improve the placement of prostheses and lower limb force lines in patients, and improve their short-term clinical prognosis. However, its application in complex hips, such as flat hip, is limited. More relevant literature is needed to further enrich people's understanding of this technology. In theory, robot assisted technology can solve many challenges faced in flat hip replacement.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * patients with Legg-Calvé-Perthes disease and accept total hip replacement in our center Exclusion Criteria: * infection, cannot complete follow-up

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07122323 on ClinicalTrials.gov ↗ ← All trials in China